Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Brian, Ron, Nick et al if I may interject my two cents....

I believe the only way the BOD would do a dividend

would be to benefit Schwartz or some other large stockholder.

Do we know of any such large stockholder?

gg

Share
New Message
Please login to post a reply